In this study, we demonstrated for the first time that pharmacological inhibition of miR-199a-5p in mouse model for MI, prevents the acetylation of the pro-hypertrophic protein P300, thus leading to protect the heart against adverse cardiac remodeling. The gene discussed is EP300; the disease is myocardial infarction.